Sj. Carlan et al., EFFECT OF INTRAMUSCULAR 15-METHYL PROSTAGLANDIN-F2-ALPHA AFTER 2ND-TRIMESTER DELIVERY, Obstetrics and gynecology, 89(1), 1997, pp. 5-9
Objective: To determine whether 15-methyl prostaglandin (PG) F-2 alpha
shortens the third stage of labor in second-trimester pregnancy loss.
Methods: This was a randomized, double-blind, placebo-controlled stud
y of women between 13 and 28 weeks' gestation admitted for spontaneous
or induced pregnancy termination. Subjects were randomized on admissi
on to receive either PG (250 mu g) or placebo (normal saline), 1 mL in
tramuscularly every 20 minutes, for a maximum of three doses if the pl
acenta had not delivered spontaneously within 10 minutes of the fetus.
A dilute oxytocin infusion was given to women in both groups. The pat
ients were managed expectantly with hourly vaginal examinations until
intervention was required or up to 6 hours, when curettage was schedul
ed. Results: Thirty-eight women received PG and 29 received placebo. T
here was no difference between the groups with regard to method of pre
gnancy termination or gestational age. There was a statistically signi
ficant decrease in the time from first injection to placental delivery
(40.0 versus 92.5 minutes; P = .02) between the PG and control groups
, respectively. Conclusions: The therapeutic use of FG in the third st
age of labor in second-trimester pregnancy loss reduces the time to co
mplete spontaneous placental delivery. (Copyright (C) 1997 by The Amer
ican College of Obstetricians and Gynecologists.)